Scientific work

Doç. Dr. Muhammed Mustafa Atcı

72 publications. The source of the information is stated next to each publication.

Back to profile

  1. Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0398 PMID 34323116 2 citations (Europe PMC) Source: OpenAlex

  2. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

    European Journal of Breast Health, 2021

    DOI 10.4274/ejbh.galenos.2020.6346 PMID 33870111 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2021

    DOI 10.1007/s12029-021-00608-y PMID 33651265 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2021

    DOI 10.29271/jcpsp.2021.12.1433 PMID 34794283 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy

    Cureus, 2021

    DOI 10.7759/cureus.14639 PMID 34046274 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Factors affecting survival in retroperitoneal sarcomas treated with upfront surgery: A real-world study by Turkish Oncology Group

    Van Yüzüncü Yıl University Academic Data Management System, 2021

    DOI 10.4999/uhod.215190 2 citations (OpenAlex) Source: OpenAlex

  7. Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer

    Journal of Surgery and Medicine, 2021

    DOI 10.28982/josam.840948 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  8. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

    Tumori Journal, 2021

    DOI 10.1177/03008916211037739 PMID 34365852 5 citations (Europe PMC) Source: OpenAlex

  9. Impact of Coronaphobia on Treatment and Follow-Up Compliance of Cancer Patients

    Future Oncology, 2021

    DOI 10.2217/fon-2021-0020 PMID 33880932 4 citations (Europe PMC) Source: OpenAlex

  10. Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck

    Cancer Chemotherapy and Pharmacology, 2021

    DOI 10.1007/s00280-021-04328-9 PMID 34312705 1 citation (Europe PMC) Source: OpenAlex

  11. La correlación entre los marcadores tumorales y los hallazgos de Ga-68DOTA-TATE PET/TC en pacientes con cáncer medular de tiroides avanzado

    Revista Española de Medicina Nuclear e Imagen Molecular, 2021

    DOI 10.1016/j.remn.2020.03.012 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  12. Assessment of abuse and related factors in older patients with cancer

    Supportive Care in Cancer, 2021

    DOI 10.1007/s00520-021-06391-7 PMID 34213643 1 citation (Europe PMC) Source: OpenAlex

  13. Predictive Importance of Vitamin D on Response to Neoadjuvant Chemotherapy in Turkish Patients with Locally Advanced Hormone Receptor Positive Breast Cancer

    Eurasian Journal of Medical Investigation, 2021

    DOI 10.14744/ejmi.2021.99947 1 citation (OpenAlex) Source: OpenAlex

  14. Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists

    Journal of Oncological Sciences, 2021

    DOI 10.37047/jos.2020-80824 Open-access full textSource: OpenAlex

  15. Tiroid Bezi ve Hastalıklarına Multidisipliner Yaklaşım

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.224 Open-access full textSource: OpenAlex

  16. Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis.

    PubMed, 2020

    PMID 33099936 10 citations (Europe PMC) Source: OpenAlex

  17. The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer

    Journal of Oncology Pharmacy Practice, 2020

    DOI 10.1177/1078155219898504 PMID 31955700 3 citations (Europe PMC) Source: OpenAlex

  18. The conversion of RAS status in metastatic colorectal cancer patients after first‐line biological agent treatment

    Colorectal Disease, 2020

    DOI 10.1111/codi.15389 PMID 33002301 3 citations (Europe PMC) Source: OpenAlex

  19. The Effect of Body Mass Index on Treatment Outcomes in Patients with Metastatic Non-Small Cell Lung Cancer Treated with Platinum-Based Therapy

    Nutrition and Cancer, 2020

    DOI 10.1080/01635581.2020.1801774 PMID 32748654 5 citations (Europe PMC) Source: OpenAlex

  20. The correlation between tumor markers and Ga-68 DOTA-TATE PET/CT findings in patients with advanced medullary thyroid cancer

    Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2020

    DOI 10.1016/j.remnie.2020.04.005 PMID 33451923 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  21. Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.

    PubMed, 2019

    PMID 31786840 5 citations (Europe PMC) Source: OpenAlex

  22. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status

    Journal of Oncological Sciences, 2019

    DOI 10.1016/j.jons.2019.08.003 2 citations (OpenAlex) Open-access full textSource: OpenAlex